← Browse by Condition
Medical Condition
male urogenital diseases
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 1, Phase 2, Phase 2
NCT06785636 Phase 1, Phase 2
Recruiting
Open-Label Study of Pocenbrodib Alone and in Combination With Abiraterone Acetate, Olaparib, or 177Lu-PSMA-617
Enrollment
252 pts
Location
United States
Sponsor
Pathos AI, Inc.
NCT06353906 Phase 2
Recruiting
Carboplatin/Paclitaxel + Pembrolizumab for Locoregionally Advanced Penile Cancer
Enrollment
27 pts
Location
Belgium, Netherlands
Sponsor
The Netherlands Cancer Institu...